07:00 , Apr 4, 2005 |  BC Week In Review  |  Company News

Ardais, Cytomyx deal

CYX purchased Ardais' biorepository business for $3 million in cash. The repository contains about 130,000 tissue samples, most of which are from cancer patients. CYX said the business had revenues of $3.7 million last year....
08:00 , Mar 14, 2005 |  BioCentury  |  Finance

Ebb & Flow

TransForm Pharmaceuticals is the third MPM portfolio company in the past few weeks to be taken out by a large pharma company. The exits could help make MPM's limited partners happy, as the firm gears...
07:00 , Aug 2, 2004 |  BC Week In Review  |  Company News

Epix Medical board of directors update

Epix Medical Inc. (EPIX), Cambridge, Mass.   Business: Diagnostic   Appointed: Gregory Phelps, formerly CEO and a director of Ardais Corp.  ...
07:00 , Apr 12, 2004 |  BC Week In Review  |  Company News

Ardais, Aventis SA deal

The partners expanded an agreement under which Ardais will assess biological targets from AVE (see BioCentury, April 15, 2002). Under the expanded deal, Ardais will help characterize targets in panels of normal and diseased human...
08:00 , Nov 24, 2003 |  BC Week In Review  |  Company News

Ardais management update

Ardais Corp. , Lexington, Mass.   Business: Supply/Service   Hired: Donald Hawthorne as president, CEO and a director, formerly CFO and partner at Ampersand Ventures; he replaces Gregory Phelps  ...
07:00 , Oct 13, 2003 |  BC Week In Review  |  Company News

Ardais sales and marketing update

Ardais launched its Biomaterials and Information for Genomic Research (BIGR) biospecimen management system (BMS). The system will enable researchers to collect, annotate, manage and distribute their human biological material resources. Ardais Corp. , Lexington, Mass....
07:00 , Sep 1, 2003 |  BioCentury  |  Finance

Ebb & Flow

A horse kept in the stable too long can turn a measured trot into a mad sprint. Not one IPO has gotten done yet, but 10 companies are already in the queue, with about $800...
07:00 , Aug 27, 2003 |  BC Extra  |  Financial News

BioVentures raises $54 million

BioVentures (Cambridge, Mass.) raised $54 million for its second private equity health care fund, which will invest in early to mid-stage rounds of companies working in drug development, medical devices, diagnostics and services. To date,...
07:00 , May 26, 2003 |  BC Week In Review  |  Company News

Ardais sales and marketing update

Ardais launched its immunohistochemistry services, including antibody specificity testing, and access to the company's BIGR library of tissue samples. Ardais Corp. , Lexington, Mass.   Business: Supply/Service  ...
07:00 , May 19, 2003 |  BC Week In Review  |  Company News

Ardais, Xantos deal

Xantos accessed Ardais's BIGR library of tissue samples and related services to validate the clinical relevance of its targets in inflammatory and degenerative diseases. Ardais Corp. , Lexington, Mass.   Xantos Biomedicine AG , Munich,...